Cytokines are chemical signalling molecules released by the immune system in response to pathological insults. Cytokine upregulation is an early feature of Alzheimer’s disease (AD) and a possible contributor to downstream neuropathology and cognitive decline. Using magnetic resonance spectroscopy (MRS), cytokine-specific enzyme-linked immunosorbent assays (ELISA) and behavioural measures, we aimed to investigate the relationships between cytokine activity, early neurochemical changes and cognitive decline in an AD rodent model. Preliminary metabolic alterations suggest a paradoxical increase in synaptic activity, coinciding with cognitive deficits. This ongoing study is a step towards understanding the impact of abnormal cytokine levels on the AD brain.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords